Abstract
Background: Anti-RhD immunoglobulins are used in immunoprophylaxis products to prevent RhD haemoltyic disease of the newborn. However, the number of available donors is decreasing structurally, mainly as a result of the success of the treatment. Therefore, this study aims to optimize the production of the donor population by finding individualized
... read more